Chengdu Biopurify Phytochemicals Ltd. is a leading company in the research, development, manufacture and marketing of High Quality Phytochemicals and Extracts, Natural Active Pharmaceutical Ingredients worldwide.From small quantities for R&D or reference standard, to large quantities for customizing or manufacturing, Biopurify emphasizes on consistent and reliable services for his customers.
In the past 20 years, it is only a flash in the long river of history, but it is a long journey enough to engrave the original intention and measure the dream for a traditional Chinese medicine enterprise that focuses on the essence of Materia Medica.
From 2006 to 2026, it started from Shudi to become a laboratory and pharmaceutical enterprise in more than 60 countries around the world; From a small team with ideals to National Institutes for Food and Drug Control (NIFDC)、European Pharmacopoeia、United States Pharmacopeia A trusted partner. “Concentrate on the essence of Materia Medica and benefit all living beings”(focus on herbal essence, let it benefit human beings) has been on the journey of modernization of traditional Chinese medicine and research and development of natural products for 20 years.
In 2026, Chengdu biopurify pharmaceuticals Ltd. ushered in an important milestone of its 20th anniversary. On the occasion of the 20th anniversary, from June 5 to 7, all employees of biopurify, led by the company's leaders, drove to Pingle Ancient Town in Qionglai to carry out the 20th anniversary celebration and expansion activities for two days and two nights. In the ancient and leisurely water town of Western Sichuan, biopurify people review the past, unite their teams and look forward to the future.
In the field of innovative drug research and development, natural products have always been the treasure house of drug discovery - from artemisinin to paclitaxel. With their unique chemical diversity and biological activity, natural products have provided countless possibilities for human disease treatment. However, the drug likeness evaluation and target research of natural products face great challenges for a long time:
On October 26, the 16th Aaes natural health products exhibition was held in the city of Zhiti bridge.The 16th Aaes natural health products exhibition.The exhibition was held in Beijing.The first of its kind in China.The second of its kind was held in Beijing..the second of its kind in the world.The second of its kind.The second of its kind, the; The Aaes natural health products industry conference and the 2nd pharmaceutical and food homology and tonic upgrading and development summit in the same period were successfully concluded at Nanjing International Exhibition Center.
On November 8, 2019, the National Pharmacopoeia Commission issued the publicity of the pilot unified standard for the varieties of traditional Chinese medicine formula granules, soliciting opinions from all sectors of society on the publicity of the pilot unified standard for 160 varieties of traditional Chinese medicine formula granules. Up to now, the three-month publicity period has ended, and the varieties of traditional Chinese medicine formula granules will be implemented according to the adopted unified standard, which marks the new stage of the standard system of traditional Chinese medicine formula granules in China.
Customers often ask about the configuration of compounds. This article makes it clear that the configuration of natural products is particularly complex. A lot of work needs to be done to determine the configuration of compounds from scratch, which is generally determined by references. The compound configuration is the characteristic of the compound itself, and the separation process generally does not lead to the configuration change, so the compounds we provide are basically their original configurations.
Alzheimer's disease (AD) has become the third most disabling and fatal disease in the elderly after cardiovascular and cerebrovascular diseases and malignant tumors, and with the increase of age, the risk of disease is significantly increased. Its clinical manifestations mainly include partial or comprehensive impairment of thinking, memory, judgment, behavior, language and other abilities. At present, the global incidence is 2% - 3% and that in China is 1% - 2%. With the aggravation of China's aging population, its prevalence is rising, and the resulting medical and economic burden is also gradually increasing [1-2]. According to the statistics of ad international organization, it is estimated that the number of dementia patients worldwide will reach 152million by 2050, of which 60% - 70% will be AD patients [3].
. Saponins are widely distributed in terrestrial plants, with a small amount in marine organisms such as sponges, starfish and corals [1]. Saponins can be divided into triterpenoids and steroidal saponins according to their aglycone carbon skeleton structure. Triterpenoid saponins are widely distributed in Leguminosae (liquorice, astragalus, etc.), Araliaceae (ginseng, Panax notoginseng, etc.), platycodonaceae (Platycodon, etc.), Polygalaceae (Polygala, etc.), Umbelliferae (bupleurum, etc.) and Caryophyllaceae; Steroidal saponins are mostly distributed in Liliaceae (Anemarrhena asphodeloides, Paris polyphylla, etc.), dioscoreaceae (Dioscorea, etc.) and Scrophulariaceae. Saponins widely exist in traditional Chinese medicine and have biological activities such as antitumor, antiviral, anti-inflammatory, antibacterial, antipyretic and sedative [2].
